BioQuest Corp.
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K eventsBioquest Corp is a pre-revenue shell-stage company that reported no revenue and is pursuing a pivot into green hydrogen technology via a letter of intent to acquire Progressus Clean Technologies.
What they do
Bioquest had intended to market, package and distribute hemp-CBD products. In 2022, after the effects of Covid, the company decided to change direction and acquire companies in the green energy sector. It has no active employees and all existing consulting contracts were put on hold at September 30, 2021. It operates on a fiscal year ending April 30.
Revenue drivers
- Historical hemp-CBD products — Previously intended CBD line; no revenue reported for the three months ended July 31, 2022 or 2021, and no annual revenue since 2014.
- Progressus Clean Technologies (proposed) — Proposed acquisition of a venture-stage hydrogen generation and separation technology company; no revenue contribution to date.
- Green energy sector acquisitions — Stated new direction to acquire green energy companies; no acquired revenue-generating operations reported.
Recent performance
For the three months ended July 31, 2022, the company reported no revenue and a net loss of $123,429, versus a net loss of $437,045 for the same period in 2021. Operating expenses fell because compensation was $0 versus $384,000 a year earlier and stock compensation was $0 versus $33,334, while professional fees rose to $47,785 from $30,793. Cash used in operating activities was $18,585 for the quarter, down from $62,254 a year earlier, and no financing cash was raised versus $65,000. At July 31, 2022, the company had cash of $14,955, current liabilities of $551,374 and a working capital deficit of $536,419. Annual net loss was $821,022 in fiscal 2022 and $2.3 million in fiscal 2021.
Strategy
Management executed a June 23, 2022 letter of intent to acquire substantially all shares of Progressus Clean Technologies, a Delaware private company developing hydrogen generation and separation technology. Progressus claims exclusive intellectual property to extract dilute hydrogen at high purity from syngas streams, using cell design, fabrication and membrane technology to enable oxygen-free electrolysis. The company states its mission is to acquire companies in the green energy sector following the effects of Covid on its prior CBD plan. No active employees remain, and management anticipates reactivating some consultants or hiring staff in the next 12 months as needed.
Risks
- Going concern and liquidity — The company had a working capital deficit of $536,419 and cash of $14,955 at July 31, 2022, and states its ability to continue as a going concern depends on raising additional capital.
- No revenue — The company reported no revenue for the three months ended July 31, 2022 or 2021, and no annual revenue since 2014.
- Uncompleted pivot — The green energy pivot rests on a letter of intent with Progressus Clean Technologies that had not closed as of the latest filing.
- No employees — The company has no active employees because all consulting contracts were put on hold at September 30, 2021.
Outlook
Management states that the company's ability to continue as a going concern depends on raising additional capital and implementing its business plan. It anticipates it can reactivate some individuals or add employees in the next 12 months as needed. The stated focus is the proposed acquisition of Progressus Clean Technologies and a broader shift into the green energy sector.